Abstract
No public abstract is available from the verified source records.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureYi Ping Lim, Nhanthinhi Jagathesan, Nadia Rashid, Yee Torng Neoh, Lee Lee Lai, Kah Seng Khoo, Joanne Mosiun, Yoke Kiet Doon, Mee Hoong See
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Unresolved referenced work
2019
Breast cancer molecular subtypes defined by ER/PR and HER2 status: association with clinicopathologic parameters in ivorian patients
10.7314/apjcp.2016.17.4.1973 · 2016
Repeated observation of breast tumor subtypes in independent gene expression data sets
10.1073/pnas.0932692100 · 2003
Molecular subtypes of breast carcinoma in Egyptian women: clinicopathological features
10.1016/j.prp.2012.03.011 · 2012
Breast cancer survival defined by the ER/PR/HER2 subtypes and a surrogate classification according to tumor grade and immunohistochemical biomarkers
10.1155/2014/469251 · 2014
Unresolved referenced work
2024
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2018
Unresolved referenced work
Kept as external metadata until matched
Correlation analysis between molecular subtypes and Nottingham Prognostic Index in breast cancer
10.18632/oncotarget.18242 · 2017
Divergent breast cancer incidence trends by hormone receptor status in the state of Sarawak, Malaysia
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
10.1002/ijc.32812 · 2020
10.1016/j.esmoop.2024.103732
10.1016/j.esmoop.2024.103732
Trends in breast cancer among elderly women: development in estrogen and HER2 subtypes in the last ten years
10.1016/j.breast.2024.103860 · 2025
Prognostic significance and molecular classification of triple negative breast cancer: a systematic review
2025
Exploring the effectiveness of molecular subtypes, biomarkers, and genetic variations as first-line treatment predictors in Asian breast cancer patients: a systematic review and meta-analysis
10.1186/s13643-024-02520-5 · 2024
Breast cancer risk factors, survival and recurrence, and tumor molecular subtype: analysis of 3012 women from an indigenous Asian population
10.1186/s13058-018-1033-8 · 2018
Breast cancer in Malaysia: the emerging trends and challenges
2021
Breast cancer in a developing country: outcomes from a tertiary care center
2019
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
10.1073/pnas.191367098 · 2001
Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study
10.1001/jama.295.21.2492 · 2006
Triple-negative breast cancer
10.1056/nejmra1001389 · 2010
Molecular subtypes of breast cancer in relation to paclitaxel benefit in the CALGB 9344 trial
2013
Pathological prognostic factors in breast cancer
2011
Five decades of progress in surgical oncology
10.1002/jso.27035 · 2022
Cancer incidence in Malaysia 2012-2016
2019
Investigation of breast cancer molecular subtype in a multi-ethnic population using MRI
10.1371/journal.pone.0309131 · 2024
Disparities in stage at diagnosis among breast cancer molecular subtypes in China
10.1002/cam4.5792 · 2023
Survival outcomes of young-age female patients with early breast cancer: an international multicenter cohort study
10.1016/j.esmoop.2024.103732 · 2024
No additional external references are available.